Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Zabini

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Frontiers in Cardiovascular Medicine|January 21, 2025
Bile acids and incretins as modulators of obesity-associated atherosclerosisAndrijana Kirsch, Juergen Gindlhuber, Diana Zabini, et al.
Acta Physiologica (Oxford, England)|August 21, 2025
Immune and Vascular Function in Cardiometabolic Disorders: Interplay With Sex Differences and Impact on Incretin TherapyAnirudh Subramanian Muralikrishnan, Valentina Biasin, Diana Zabini, et al.
Cell and Tissue Research|November 4, 2016
Animal models of sarcoidosisYijie Hu, Betel Yibrehu, Diana Zabini, et al.
American Journal of Respiratory and Critical Care Medicine|May 29, 2020
TMEM16A Potentiation: Possible DrawbacksAndrea Olschewski, Chandran Nagaraj, Diana Zabini, et al.
Pharmacology & Therapeutics|July 25, 2022
Chloride channels in the lung: Challenges and perspectives for viral infections, pulmonary arterial hypertension, and cystic fibrosisMadhushri Sinha, Diana Zabini, Divya Guntur, et al.
American Journal of Respiratory and Critical Care Medicine|April 10, 2018
The Role of the Human Immune System in Chronic Hypoxic Pulmonary HypertensionYijie Hu, Diana Zabini, Wei Gu, et al.
Journal of Cellular and Molecular Medicine|March 3, 2015
High-mobility group box-1 induces vascular remodelling processes via c-Jun activationDiana Zabini, Slaven Crnkovic, Hui Xu, et al.
Plos One|August 24, 2012
Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunctionDiana Zabini, Chandran Nagaraj, Elvira Stacher, et al.
Frontiers in Physiology|June 6, 2018
Rho-Kinase Inhibition Ameliorates Dasatinib-Induced Endothelial Dysfunction and Pulmonary HypertensionCsilla Fazakas, Chandran Nagaraj, Diana Zabini, et al.
The European Respiratory Journal|July 19, 2014
Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patientsDiana Zabini, Akos Heinemann, Vasile Foris, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Frontiers in Cardiovascular Medicine|January 21, 2025
Bile acids and incretins as modulators of obesity-associated atherosclerosisAndrijana Kirsch, Juergen Gindlhuber, Diana Zabini, et al.
Acta Physiologica (Oxford, England)|August 21, 2025
Immune and Vascular Function in Cardiometabolic Disorders: Interplay With Sex Differences and Impact on Incretin TherapyAnirudh Subramanian Muralikrishnan, Valentina Biasin, Diana Zabini, et al.
Cell and Tissue Research|November 4, 2016
Animal models of sarcoidosisYijie Hu, Betel Yibrehu, Diana Zabini, et al.
American Journal of Respiratory and Critical Care Medicine|May 29, 2020
TMEM16A Potentiation: Possible DrawbacksAndrea Olschewski, Chandran Nagaraj, Diana Zabini, et al.
Pharmacology & Therapeutics|July 25, 2022
Chloride channels in the lung: Challenges and perspectives for viral infections, pulmonary arterial hypertension, and cystic fibrosisMadhushri Sinha, Diana Zabini, Divya Guntur, et al.
American Journal of Respiratory and Critical Care Medicine|April 10, 2018
The Role of the Human Immune System in Chronic Hypoxic Pulmonary HypertensionYijie Hu, Diana Zabini, Wei Gu, et al.
Journal of Cellular and Molecular Medicine|March 3, 2015
High-mobility group box-1 induces vascular remodelling processes via c-Jun activationDiana Zabini, Slaven Crnkovic, Hui Xu, et al.
Plos One|August 24, 2012
Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunctionDiana Zabini, Chandran Nagaraj, Elvira Stacher, et al.
Frontiers in Physiology|June 6, 2018
Rho-Kinase Inhibition Ameliorates Dasatinib-Induced Endothelial Dysfunction and Pulmonary HypertensionCsilla Fazakas, Chandran Nagaraj, Diana Zabini, et al.
The European Respiratory Journal|July 19, 2014
Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patientsDiana Zabini, Akos Heinemann, Vasile Foris, et al.
Pageof 3